Companies / Forte Biosciences, Inc.

Forte Biosciences, Inc.

Nasdaq: FBRXCIK 1419041DALLAS, TX

Financials · FY2019

Revenue$36.0K
Net income$-69.38M
Total debt$22.08M
Cash$49.63M
Diluted EPS$-4.71
Shares outstanding21.2M

Ownership

21.2M shares outstanding · as of Aug 7, 2026
0.59%Insiders
Ownership
Insiders0.59%125,160
10%+ / strategic5.82%1,235,614
Institutions64.02%13,590,533
Public float29.57%6,277,780

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 4

View all →
Insider% of sharesShares
Wagner Paul A.SEE REMARKS · Director
0.39%83,178
Riley Antony ACHIEF FINANCIAL OFFICER
0.20%41,982

Institutional holders 62

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Dec 30, 2025Riley Antony A
Executive
BuyCommon Stock$254.8K+10K
+30.40%
41,520
0.20% of shares
medium
Jan 1, 2026Wagner Paul A.
Executive
OtherCommon Stock$4.5K-164
-0.20%
83,178
0.39% of shares
low
Jan 1, 2026Riley Antony A
Executive
OtherCommon Stock$4.2K-154
-0.37%
41,741
0.20% of shares
low
Apr 1, 2026Riley Antony A
Executive
OtherCommon Stock$3.3K-134
-0.32%
41,982
0.20% of shares
low
Jan 1, 2026Wagner Paul A.
Executive
ExerciseCommon Stock$0+1K
+1.52%
83,342
0.39% of shares
low
Jan 1, 2026Riley Antony A
Executive
ExerciseCommon Stock$0+375
+0.90%
41,895
0.20% of shares
low
Jun 16, 2026Riley Antony A
Executive
GrantStock Option (right to buy)+22K
22,000
0.10% of shares
low
Apr 1, 2026Riley Antony A
Executive
ExerciseRestricted Stock Units-375
-25.00%
1,125
<0.01% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Alger Associates, Inc.Passive13G/A935,514
Janus Henderson Group PLCPassive13G/A
Janus Henderson Group PLCPassive13G/A
Oliveira Steven MichaelPassive13G/A300,100
Affinity Asset Advisors, LLCPassive13G/A
Point72 Asset Management, L.P.Passive13G
Alger Associates, Inc.Passive13G/A1,272,596
Orbimed Advisors LLCPassive13G/A

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
FBRX34962G208